We are live on ! Find out more
CTKB icon

Cytek Biosciences

54 hedge funds and large institutions have $744M invested in Cytek Biosciences in 2021 Q3 according to their latest regulatory filings, with 54 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

25.69% more ownership

Funds ownership: 0%25.69% (+26%)

Holders
54
Holders Change
+54
Holders Change %
% of All Funds
0.95%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
54
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$875K +$962K +40,915 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$826K +$907K +38,569 New
N
28
Nuveen
North Carolina
$494K +$543K +23,086 New
Citadel Advisors
29
Citadel Advisors
Florida
$328K +$360K +15,318 New
PP
30
Paloma Partners
Connecticut
$278K +$305K +12,987 New
JP Morgan Chase
31
JP Morgan Chase
New York
$277K +$304K +12,936 New
RhumbLine Advisers
32
RhumbLine Advisers
Massachusetts
$252K +$277K +11,761 New
CPIG
33
Chicago Partners Investment Group
Illinois
$212K +$219K +9,323 New
Deutsche Bank
34
Deutsche Bank
Germany
$212K +$232K +9,876 New
AIG
35
American International Group
New York
$188K +$207K +8,789 New
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$186K +$204K +8,677 New
CSS
37
Cubist Systematic Strategies
Connecticut
$184K +$202K +8,600 New
SG Americas Securities
38
SG Americas Securities
New York
$148K +$162K +6,890 New
MIM
39
MetLife Investment Management
New Jersey
$138K +$152K +6,449 New
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$120K +$132K +5,600 New
MLICM
41
Metropolitan Life Insurance Company (MetLife)
New York
$104K +$115K +4,879 New
SO
42
STRS Ohio
Ohio
$79K +$87K +3,700 New
Citigroup
43
Citigroup
New York
$48K +$52.4K +2,227 New
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$40K +$43.4K +1,843 New
Legal & General Group
45
Legal & General Group
United Kingdom
$34K +$37.6K +1,600 New
AIP
46
Ameritas Investment Partners
Nebraska
$26K +$29K +1,231 New
UBS Group
47
UBS Group
Switzerland
$18K +$19.5K +831 New
PHK
48
Point72 Hong Kong
Hong Kong
$16K +$17.6K +749 New
TRCT
49
Tower Research Capital (TRC)
New York
$11K +$12K +509 New
US Bancorp
50
US Bancorp
Minnesota
$7K +$7.53K +320 New

CTKB Hedge Fund Activity: Q3 2021 in Review

54 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Cytek Biosciences (CTKB) for Q3 2021, worth a combined $744M.

Buyers outnumbered sellers: 54 funds opened new CTKB positions and 0 closed out — a net gain of 54 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $226M.

  • 54 institutional investors held Cytek Biosciences (CTKB) as of Q3 2021, up from 0 in Q2 2021.
  • Funds reported $744M of Cytek Biosciences stock for Q3 2021.
  • 54 funds opened new Cytek Biosciences positions in Q3 2021 and 0 closed out, a net change of +54 holders.
  • The largest Cytek Biosciences buyer in Q3 2021 was RA Capital Management, an estimated $226M added.

Based on aggregated 13F filings for Q3 2021.